3,059,387 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Norges Bank

Norges Bank purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,059,387 shares of the real estate investment trust’s stock, valued at approximately $57,945,000.

Other hedge funds have also recently bought and sold shares of the company. Rothschild Investment LLC boosted its holdings in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the last quarter. Founders Capital Management bought a new stake in Sabra Healthcare REIT during the third quarter worth $28,000. Strengthening Families & Communities LLC bought a new stake in Sabra Healthcare REIT during the fourth quarter worth $29,000. Danske Bank A S acquired a new stake in Sabra Healthcare REIT in the third quarter valued at $30,000. Finally, Larson Financial Group LLC grew its position in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $18.46 on Monday. The firm has a market cap of $4.66 billion, a P/E ratio of 29.30, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The business’s 50 day moving average is $20.15 and its 200-day moving average is $19.69. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday. Cantor Fitzgerald boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday, May 18th. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, UBS Group boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and a consensus target price of $22.40.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.